BL Pharmtech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	50,879	14,620	20,819	44,929	55,605	116,549
Market Cap Growth	95.57%	-29.77%	-53.66%	-19.20%	-52.29%	-20.02%
Enterprise Value	47,774	17,550	25,570	86,785	100,284	144,445
Last Close Price	1823.00	548.00	780.00	1683.33	2083.33	4366.67
PS Ratio	10.10	2.25	2.36	1.83	2.47	1.38
PB Ratio	4.93	1.84	0.86	1.41	1.35	1.78
P/TBV Ratio	4.97	1.87	0.87	1.46	2.26	2.66
P/FCF Ratio	-	-	-	5.85	-	46.44
P/OCF Ratio	-	-	-	5.62	-	37.64
EV/Sales Ratio	9.49	2.70	2.90	3.54	4.45	1.71
EV/FCF Ratio	-	-	-	11.30	-	57.56
Debt / Equity Ratio	0.34	0.64	0.25	0.13	1.04	0.64
Debt / FCF Ratio	-	-	-	0.56	-	16.69
Net Debt / Equity Ratio	-0.30	-0.27	0.09	-0.28	0.91	0.29
Net Debt / EBITDA Ratio	-67.99	1.43	-0.64	1.43	-9.56	-130.44
Net Debt / FCF Ratio	1.26	7.43	-0.53	-1.16	-2.93	7.63
Asset Turnover	0.18	0.24	0.22	0.33	0.19	0.64
Inventory Turnover	2.51	2.63	1.64	1.32	0.87	6.68
Quick Ratio	1.13	0.89	0.73	1.79	0.34	0.90
Current Ratio	1.23	0.95	1.05	2.12	0.67	1.14
Return on Equity (ROE)	-91.00%	-104.28%	-20.39%	-37.90%	-27.09%	-29.05%
Return on Assets (ROA)	-0.98%	-4.65%	-6.68%	-5.99%	-2.56%	-1.70%
Return on Invested Capital (ROIC)	-6.77%	-12.58%	-17.60%	-14.08%	-5.88%	-3.80%
Return on Capital Employed (ROCE)	-3.80%	-22.10%	-14.60%	-19.30%	-8.80%	-3.90%
Earnings Yield	-29.85%	-114.76%	-27.41%	-0.33%	-25.00%	-17.34%
FCF Yield	-	-1.94%	-20.19%	17.09%	-22.85%	2.15%
Buyback Yield / Dilution	-0.01%	-0.05%	0.09%	0.00%	-1.33%	-18.44%